The June issue is live nature.com/nbt/volumes/44/is…
The cover shows an illustration of vascularized tumors on a chip. Liu et al. present a long‑term, perfused system for human solid tumors that supports CAR‑T delivery and real‑time analysis of tumor–CAR‑T dynamics, evaluation of engineering strategies, and identification of druggable targets go.nature.com/3Jc62gvrdcu.be/foISS
Excited to share our latest work, now published in @NatureBiotech! We established the first prime editing platform for filamentous fungi, achieving average editing efficiencies approaching 90% across diverse loci and species. nature.com/articles/s41587-0…
Each year, we highlight companies that received sizeable early-stage funding in the previous year. Trogenix has developed a platform for generating ‘synthetic super-enhancers’ that could drive highly cell-specific gene therapy-based treatment of solid tumors such as glioblastoma nature.com/articles/s41587-0…
A plug-and-play system fine-tunes multiple targets simultaneously for secondary metabolite production in Streptomyces go.nature.com/3HdTOTVrdcu.be/fpOVH
With endless curiosity and persistence, this biologist is motivated by the prospect of developing stem cell technologies that could one day repair damaged organs or even create new organs for transplantation nature.com/articles/s41587-0…rdcu.be/fpQOo
Mass spectrometry and wearable sensor technology are complementary approaches that, when integrated, can co-evolve to open new possibilities for noninvasive health monitoring go.nature.com/4rvOjASrdcu.be/fpQNs